[platz]

> alternative therapies have a price tag of up to $300k/yr

So prices should all float to the maximum of the most inferior product, so that consumers do not have a choice?

How would you like that if it happened in your favorite consumer category?

That's like saying computer memory should never get cheaper (there is alternative memory priced at much higher rates!), or that electric vehicles should always be priced at the cost of the initial entrants, despite economies of scale

[tptacek]

What are you talking about? The premise of this product was that it cost a fraction of what existing treatments cost, and was far better. That's the opposite of the dynamic you just described.

[platz]

Even most of the folks described in the article did not have an initial reaction of "It only costs a fraction of existing methods!" Instead, their reaction was that the price was set by forces that had nothing to do with the R&D of the drug, and by that measure, it costs far much more that it otherwise could be. When the patent expires, a generic alternative will likely be made for far cheaper.

[tptacek]

What patent are you referring to? Are you sure it's still under patent? Did you read anything about Glybera other than this story? Want some spoilers?

[platz]

I've only read this story on it.

I assumed the patent information based on other commenters, perhaps those were incorrect.

I never watch the trailers before I go to watch a movie.

[ZeikJT]

Here we are discussing the Real Events the movie was based on when all we've seen are the Movie Adaptation and Metacritic.